tiprankstipranks
Trending News
More News >
Oxford BioMedica plc (OXBDF)
OTHER OTC:OXBDF

Oxford BioMedica (OXBDF) Stock Statistics & Valuation Metrics

Compare
63 Followers

Total Valuation

Oxford BioMedica has a market cap or net worth of $493.00M. The enterprise value is $412.54M.
Market Cap$493.00M
Enterprise Value$412.54M

Share Statistics

Oxford BioMedica has 106,093,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding106,093,860
Owned by Insiders<0.01%
Owned by Institutions2.15%

Financial Efficiency

Oxford BioMedica’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -23.33%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-23.33%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee151.53K
Profits Per Employee-55.61K
Employee Count850
Asset Turnover0.56
Inventory Turnover5.58

Valuation Ratios

The current PE Ratio of Oxford BioMedica is -10.06. Oxford BioMedica’s PEG ratio is -0.12.
PE Ratio-10.06
PS Ratio0.00
PB Ratio6.38
Price to Fair Value7.62
Price to FCF-6.22
Price to Operating Cash Flow-7.13
PEG Ratio-0.12

Income Statement

In the last 12 months, Oxford BioMedica had revenue of 128.80M and earned -43.19M in profits. Earnings per share was -0.42.
Revenue128.80M
Gross Profit53.02M
Operating Income-39.38M
Pretax Income-47.27M
Net Income-43.19M
EBITDA-14.33M
Earnings Per Share (EPS)-0.42

Cash Flow

In the last 12 months, operating cash flow was -51.05M and capital expenditures -7.50M, giving a free cash flow of -58.55M billion.
Operating Cash Flow-51.05M
Free Cash Flow-58.55M
Free Cash Flow per Share-0.55

Dividends & Yields

Oxford BioMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.35
52-Week Price Change12.24%
50-Day Moving Average3.97
200-Day Moving Average4.71
Relative Strength Index (RSI)64.43
Average Volume (3m)85.00

Important Dates

Oxford BioMedica upcoming earnings date is Apr 9, 2025, TBA Not Confirmed.
Last Earnings DateSep 23, 2024
Next Earnings DateApr 9, 2025
Ex-Dividend Date

Financial Position

Oxford BioMedica as a current ratio of 2.28, with Debt / Equity ratio of 190.65%
Current Ratio2.28
Quick Ratio2.05
Debt to Market Cap0.09
Net Debt to EBITDA-3.36
Interest Coverage Ratio-4.00

Taxes

In the past 12 months, Oxford BioMedica has paid 1.34M in taxes.
Income Tax1.34M
Effective Tax Rate-0.03

Enterprise Valuation

Oxford BioMedica EV to EBITDA ratio is -33.67, with an EV/FCF ratio of -8.30.
EV to Sales3.75
EV to EBITDA-33.67
EV to Free Cash Flow-8.30
EV to Operating Cash Flow-9.53

Balance Sheet

Oxford BioMedica has $60.65M in cash and marketable securities with £108.76M in debt, giving a net cash position of $48.11M billion.
Cash & Marketable Securities$60.65M
Total Debt£108.76M
Net Cash$48.11M
Net Cash Per Share$0.45
Tangible Book Value Per Share$0.30

Margins

Gross margin is 40.90%, with operating margin of -30.57%, and net profit margin of -33.53%.
Gross Margin40.90%
Operating Margin-30.57%
Pretax Margin-36.70%
Net Profit Margin-33.53%
EBITDA Margin-11.13%
EBIT Margin-29.06%

Analyst Forecast

The average price target for Oxford BioMedica is $8.81, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.81
Price Target Upside84.70% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score5
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis